TrialClinical and translational science2021

Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19.

Nathan D Pfeifer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.